News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current BCRX market cap is 913.24M. The company's latest EPS is USD -1.0989 and P/E is -4.03.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 75.83M | 79.55M | 68.78M | 82.49M | 86.74M |
| Operating Income | -17.45M | -46.31M | -28.42M | -20.7M | -19.26M |
| Net Income | -42.52M | -71.54M | -53.33M | -75.33M | -36.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 48.84M | 17.81M | 157.17M | 270.83M | 331.41M |
| Operating Income | -99.46M | -174.76M | -177.72M | -148.44M | -103.71M |
| Net Income | -108.9M | -182.81M | -184.06M | -247.12M | -226.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 558.59M | 550M | 509.74M | 529.89M | 522.92M |
| Total Liabilities | 801.25M | 844.6M | 838.02M | 918.6M | 933.91M |
| Total Equity | -242.66M | -294.6M | -328.29M | -388.71M | -410.99M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 175.28M | 334.72M | 588.15M | 550M | 516.96M |
| Total Liabilities | 137.03M | 353.98M | 695.14M | 844.6M | 972.49M |
| Total Equity | 38.25M | -19.26M | -106.99M | -294.6M | -455.53M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -138M | -161.85M | -47.51M | -66.33M | -86.22M |
| Investing | -205.45M | -128.24M | -107.11M | -126.14M | -103.03M |
| Financing | 83.83M | 88.03M | 5.08M | 34.43M | 35.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -89.58M | -137.22M | -142.16M | -161.85M | -95.14M |
| Investing | 77.93M | -6.86M | 15.8M | -128.24M | -131.5M |
| Financing | 99.1M | 302.7M | 359.67M | 88.03M | 32.49M |
| Market Cap | 913.24M |
| Price to Earnings Ratio | -4.03 |
| Price to Sales Ratio | 2.76 |
| Price to Cash Ratio | 8.25 |
| Price to Book Ratio | -2 |
| Dividend Yield | - |
| Shares Outstanding | 206.15M |
| Average Volume (1 week) | 3.2M |
| Average Volume (1 Month) | 3.06M |
| 52 Week Change | -40.62% |
| 52 Week High | 9.065 |
| 52 Week Low | 4.27 |
| Spread (Intraday) | 0.06 (1.34%) |
| Company Name | BioCryst Pharmaceuticals Inc |
| Address |
2711 centerville road wilmington, delaware 19808 |
| Website | https://www.biocryst.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
